Biomind Labs Inc. (BMNDF)
OTCMKTS · Delayed Price · Currency is USD
0.4600
0.00 (0.00%)
Oct 8, 2026, 4:00 PM EST
Biomind Labs Market Cap
Biomind Labs has a market cap or net worth of $35.68 million as of October 9, 2026. It is the 32,928th most valuable company in the world and the 4,892nd biggest in the United States. Its market cap has increased by 2,811.39% in one year.
Market Cap
35.68M
Enterprise Value
36.51M
Revenue
n/a
Global Rank
Country Rank
#4,892 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since July 27, 2021, Biomind Labs's market cap has increased from 18.69M to 35.68M, an increase of 90.92%. That is a compound annual growth rate of 13.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 35.68M | 303.51% |
| Dec 30, 2025 | 8.84M | -67.68% |
| Dec 19, 2022 | 27.36M | 46.40% |
| Jul 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NDT Pharmaceuticals | 63.05M |
| Nuo Therapeutics | 62.96M |
| ProText Mobility | 61.54M |
| Sangamo Therapeutics | 58.00M |
| Zenith Capital | 48.27M |
| Arch Biopartners | 40.08M |
| Cell Source | 37.55M |
| EOM Pharmaceuticals Holdings | 21.25M |